Compound Evidence File
#EC-2026-0208
Drostanolone Enanthate (Mast E) Raw
Filed under Raw Materials. The bureau holds 122 laboratory returns for this compound from 47 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
47 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| HomopeptideCASE #VI-2026-0760 | A | 6 | 10.0 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 10.0 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 4 | 10.0 | 9.9 | 10.0 | 19 Jan 2026 | 8 Jul 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 4 | 10.0 | 10.0 | 10.0 | 28 Jan 2026 | 13 Jul 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 4 | 10.0 | 9.9 | 10.0 | 15 Mar 2026 | 6 Jul 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 3 | 10.0 | 9.9 | 10.0 | 10 Nov 2025 | 3 Jun 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Apr 2026 | 2 Jul 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 17 Apr 2026 | 12 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 3 | 10.0 | 10.0 | 10.0 | 16 Feb 2026 | 13 Jun 2026 |
| Hubei JianxiangCASE #VI-2026-0048 | A | 3 | 10.0 | 9.9 | 10.0 | 21 May 2026 | 21 Jun 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 10.0 | 10.0 | 2 Jan 2026 | 10 May 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 10.0 | 9.9 | 10.0 | 23 Mar 2026 | 26 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 3 | 10.0 | 9.9 | 10.0 | 13 Jun 2026 | 22 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 9.9 | 10.0 | 10 May 2026 | 17 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 4 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 3 Jul 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 5 Mar 2026 | 11 Jul 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 4 | 9.9 | 9.9 | 10.0 | 8 Dec 2025 | 19 Mar 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 9.9 | 9.9 | 10.0 | 7 Dec 2025 | 9 Jun 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 9.9 | 9.9 | 10.0 | 9 Apr 2026 | 5 Aug 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 14 Jan 2026 | 19 May 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 3 | 9.9 | 9.9 | 10.0 | 19 Dec 2025 | 8 Jun 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 7 Mar 2026 | 23 May 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 9.9 | 9.9 | 10.0 | 14 Jul 2026 | 17 Jul 2026 |
| Kits4lessCASE #VI-2026-0744 | X | 1 | 9.0 | 9.0 | 9.0 | 16 Mar 2025 | 16 Mar 2025 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 3 | 8.8 | 7.1 | 10.0 | 21 May 2026 | 21 May 2026 |
| Peptide PartnersCASE #VI-2026-0295 | X | 4 | 8.8 | 6.3 | 10.0 | 14 Jan 2025 | 23 May 2026 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 5 | 8.7 | 6.0 | 9.8 | 21 May 2026 | 21 May 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 4 | 8.3 | 7.1 | 9.2 | 23 May 2026 | 23 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 3 | 8.0 | 7.2 | 9.5 | 23 May 2026 | 23 May 2026 |
| Peptide TechnologiesCASE #VI-2026-0694 | X | 1 | 8.0 | 8.0 | 8.0 | 24 Apr 2025 | 24 Apr 2025 |
| Astro PeptidesCASE #VI-2026-0424 | X | 2 | 7.8 | 7.6 | 7.9 | 21 May 2025 | 21 May 2026 |
| Top PeptideCASE #VI-2026-0721 | X | 1 | 7.8 | 7.8 | 7.8 | 6 May 2025 | 6 May 2025 |
| NextechLabsCASE #VI-2026-0285 | X | 2 | 7.5 | 5.9 | 9.2 | 7 May 2025 | 23 May 2026 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 2 | 7.4 | 6.4 | 8.4 | 21 May 2026 | 21 May 2026 |
| Mix PeptidesCASE #VI-2026-0699 | X | 1 | 7.2 | 7.2 | 7.2 | 3 Jun 2025 | 3 Jun 2025 |
| Hangzhou Youngpeptide Biotechnology HYBCASE #VI-2026-0347 | X | 1 | 7.1 | 7.1 | 7.1 | 17 Dec 2024 | 17 Dec 2024 |
| AKS ChemCASE #VI-2026-0313 | X | 1 | 6.8 | 6.8 | 6.8 | 9 Jun 2025 | 9 Jun 2025 |
| Dragon PharmaCASE #VI-2026-0519 | X | 1 | 6.6 | 6.6 | 6.6 | 7 May 2025 | 7 May 2025 |
| HazelCASE #VI-2026-0392 | X | 1 | 6.6 | 6.6 | 6.6 | 9 Jun 2025 | 9 Jun 2025 |
| Chimera PeptidesCASE #VI-2026-0260 | X | 1 | 6.5 | 6.5 | 6.5 | 2 Apr 2025 | 2 Apr 2025 |
| Zen PeptidesCASE #VI-2026-0940 | X | 1 | 6.3 | 6.3 | 6.3 | 21 May 2025 | 21 May 2025 |
| Suaway Lab ResearchCASE #VI-2026-0488 | X | 2 | 5.2 | 4.5 | 5.8 | 11 Jun 2025 | 20 May 2026 |
| Amino AsylumCASE #VI-2026-0828 | X | 1 | 4.8 | 4.8 | 4.8 | 8 Jul 2025 | 8 Jul 2025 |
| Peptronix Bio PTBCASE #VI-2026-0979 | X | 1 | 4.8 | 4.8 | 4.8 | 21 May 2025 | 21 May 2025 |
| Explicit SarmsCASE #VI-2026-0017 | X | 1 | 0.8 | 0.8 | 0.8 | 17 Dec 2024 | 17 Dec 2024 |
| LOOKBiotechCASE #VI-2026-0807 | X | 1 | 0.0 | 0.0 | 0.0 | 2 Jul 2025 | 2 Jul 2025 |
| Weifang Xingbei International TradeCASE #VI-2026-0766 | X | 1 | 0.0 | 0.0 | 0.0 | 21 May 2025 | 21 May 2025 |
Open any subject to view the batch-level evidence for Drostanolone Enanthate (Mast E) Raw alone.